Biallelic variants in ERLIN1: a series of 13 individuals with spastic paraparesis.
Journal
Human genetics
ISSN: 1432-1203
Titre abrégé: Hum Genet
Pays: Germany
ID NLM: 7613873
Informations de publication
Date de publication:
04 Oct 2024
04 Oct 2024
Historique:
received:
17
07
2024
accepted:
09
09
2024
medline:
5
10
2024
pubmed:
5
10
2024
entrez:
4
10
2024
Statut:
aheadofprint
Résumé
Biallelic variants in the ERLIN1 gene were recently reported as the cause of two motor neuron degeneration diseases, SPG62 and a recessive form of amyotrophic lateral sclerosis. However, only 12 individuals from five pedigrees have been identified so far. Thus, the description of the disease remains limited. Following the discovery of a homozygous pathogenic variant in a girl with SPG62, presenting with intellectual disability, and epilepsy, we gathered the largest series of SPG62 cases reported so far (13 individuals) to better understand the phenotype associated with ERLIN1. We collected molecular and clinical data for 13 individuals from six families with ERLIN1 biallelic variants. We performed RNA-seq analyses to characterize intronic variants and used Alphafold and a transcripts database to characterize the molecular consequences of the variants. We identified three new variants suspected to alter the bell-shaped ring formed by the ERLIN1/ERLIN2 complex. Affected individuals had childhood-onset paraparesis with slow progression. Six individuals presented with gait ataxia and three had superficial sensory loss. Aside from our proband, none had intellectual disability or epilepsy. Biallelic pathogenic ERLIN1 variants induce a rare, predominantly pure, spastic paraparesis, with possible cerebellar and peripheral nerve involvement.
Identifiants
pubmed: 39367212
doi: 10.1007/s00439-024-02702-0
pii: 10.1007/s00439-024-02702-0
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Alazami AM, Adly N, Dhalaan HA, Alkuraya FS (2011) A Nullimorphic ERLIN2 mutation defines a complicated hereditary spastic paraplegia locus (SPG18). Neurogenetics 12(4):333–336. https://doi.org/10.1007/s10048-011-0291-8
doi: 10.1007/s10048-011-0291-8
pubmed: 21796390
pmcid: 3215864
Berridge MJ (2016) The inositol trisphosphate/calcium signaling pathway in health and disease. Physiol Rev 96(4):1261–1296. https://doi.org/10.1152/physrev.00006.2016
doi: 10.1152/physrev.00006.2016
pubmed: 27512009
Browman DT, Resek ME, Zajchowski LD, Robbins SM (2006) Erlin-1 and Erlin-2 are novel members of the prohibitin family of proteins that define lipid-raft-like domains of the ER. J Cell Sci 119(Pt 15):3149–3160. https://doi.org/10.1242/jcs.03060
doi: 10.1242/jcs.03060
pubmed: 16835267
Chen S, Francioli LC, Goodrich JK, Collins RL, Kanai M, Wang Q, Alföldi J et al (2024) A genomic mutational constraint map using variation in 76,156 human genomes. Nature. https://doi.org/10.1038/s41586-023-06045-0
doi: 10.1038/s41586-023-06045-0
pubmed: 39353570
pmcid: 11424481
Darios Fr, Coarelli G, Durr A (2022) Genetics in hereditary spastic paraplegias: essential but not enough. Curr Opin Neurobiol 72(1):8–14. https://doi.org/10.1016/j.conb.2021.07.005
doi: 10.1016/j.conb.2021.07.005
pubmed: 34403957
Daumke O, Lewin GR (2022) SPFH protein cage—one ring to rule them all. Cell Res 32(2):117–118. https://doi.org/10.1038/s41422-021-00605-7
doi: 10.1038/s41422-021-00605-7
pubmed: 34931034
Fagerberg L, Hallström BM, Oksvold P, Kampf C, Djureinovic D, Odeberg J, Habuka M et al (2014) Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteom MCP 13(2):397–406. https://doi.org/10.1074/mcp.M113.035600
doi: 10.1074/mcp.M113.035600
pubmed: 24309898
Gao Xi, Wojcikiewicz RJH (2020) The emerging link between IP3 receptor turnover and hereditary spastic paraplegia. Cell Calcium 86(amrs):102142. https://doi.org/10.1016/j.ceca.2019.102142
doi: 10.1016/j.ceca.2019.102142
pubmed: 31874412
Harding AE (1983) Classification of the hereditary ataxias and paraplegias. Lancet (London, England) 1(8334):1151–1155. https://doi.org/10.1016/s0140-6736(83)92879-9
doi: 10.1016/s0140-6736(83)92879-9
pubmed: 6133167
Helms JB, Zurzolo C (2004) Lipids as targeting signals: lipid rafts and intracellular trafficking. Traffic (Copenhagen, Denmark) 5(4):247–254. https://doi.org/10.1111/j.1600-0854.2004.0181.x
doi: 10.1111/j.1600-0854.2004.0181.x
pubmed: 15030566
Hoegg MB, Browman DT, Resek ME, Robbins SM (2009) Distinct regions within the Erlins are required for oligomerization and association with high molecular weight complexes. J Biol Chem 284(12):7766–7776. https://doi.org/10.1074/jbc.M809127200
doi: 10.1074/jbc.M809127200
pubmed: 19131330
pmcid: 2658070
Iskender C, Kartal E, Akcimen F, Kocoglu C, Ozoguz A, Kotan D, Eraksoy M, Parman YG, Basak AN (2015) Turkish families with juvenile motor neuron disease broaden the phenotypic spectrum of SPG11. Neurol Genet 1(3):e25. https://doi.org/10.1212/NXG.0000000000000025
doi: 10.1212/NXG.0000000000000025
pubmed: 27066562
pmcid: 4809458
Jm dSA, Filser M, Isidor B, Besnard T, Gueguen P, Perrin A, Van Goethem C et al (2023) SpliceAI-visual: a free online tool to improve SpliceAI splicing variant interpretation. Human Genom. https://doi.org/10.1186/s40246-023-00451-1
doi: 10.1186/s40246-023-00451-1
Kingsmore SF, Henderson A, Owen MJ, Clark MM, Hansen C, Dimmock D, Chambers CD, Jeliffe-Pawlowski LL, Hobbs C (2020) Measurement of genetic diseases as a cause of mortality in infants receiving whole genome sequencing. NPJ Genom Med 5:49. https://doi.org/10.1038/s41525-020-00155-8
doi: 10.1038/s41525-020-00155-8
pubmed: 33154820
pmcid: 7608690
Kircher M, Witten DM, Jain P, O’Roak BJ, Cooper GM, Shendure J (2014) A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet 46(3):310–315. https://doi.org/10.1038/ng.2892
doi: 10.1038/ng.2892
pubmed: 24487276
pmcid: 3992975
Ma C, Wang C, Dingyi Luo Lu, Yan WY, Li N, Gao N (2022) Structural insights into the membrane microdomain organization by SPFH family proteins. Cell Res 32(2):176–189. https://doi.org/10.1038/s41422-021-00598-3
doi: 10.1038/s41422-021-00598-3
pubmed: 34975153
pmcid: 8807802
Manganelli V, Longo A, Mattei V, Recalchi S, Riitano G, Caissutti D, Capozzi A, Sorice M, Misasi R, Garofalo T (2021) Role of ERLINs in the control of cell fate through lipid rafts. Cells 10(9):2408. https://doi.org/10.3390/cells10092408
doi: 10.3390/cells10092408
pubmed: 34572057
pmcid: 8470593
Novarino G, Fenstermaker AG, Zaki MS, Hofree M, Silhavy JL, Heiberg AD, Abdellateef M et al (2014) Exome sequencing links corticospinal motor neuron disease to common neurodegenerative disorders. Science (New York, N.y.) 343(6170):506–511. https://doi.org/10.1126/science.1247363
doi: 10.1126/science.1247363
pubmed: 24482476
Ouweneel AB, Thomas MJ, Sorci-Thomas MG (2020) The ins and outs of lipid rafts: functions in intracellular cholesterol homeostasis, microparticles, and cell membranes: thematic review series: biology of lipid rafts. J Lipid Res 61(5):676–686. https://doi.org/10.1194/jlr.TR119000383
doi: 10.1194/jlr.TR119000383
pubmed: 33715815
Park J-M, Lee B, Kim J-H, Park S-Y, Jinhoon Yu, Kim U-K, Park J-S (2020) An autosomal dominant ERLIN2 mutation leads to a pure HSP phenotype distinct from the autosomal recessive ERLIN2 mutations (SPG18). Sci Rep 10(1):3295. https://doi.org/10.1038/s41598-020-60374-y
doi: 10.1038/s41598-020-60374-y
pubmed: 32094424
pmcid: 7039913
Parodi L, Fenu S, Stevanin G, Durr A (2017) Hereditary spastic paraplegia: more than an upper motor neuron disease. Revue Neurologique 173(5):352–360. https://doi.org/10.1016/j.neurol.2017.03.034
doi: 10.1016/j.neurol.2017.03.034
pubmed: 28449883
Pearce MMP, Wang Y, Kelley GG, Wojcikiewicz RJH (2007) SPFH2 mediates the endoplasmic reticulum-associated degradation of inositol 1,4,5-trisphosphate receptors and other substrates in mammalian cells. J Biol Chem 282(28):20104–20115. https://doi.org/10.1074/jbc.M701862200
doi: 10.1074/jbc.M701862200
pubmed: 17502376
Pearce MMP, Wormer DB, Wilkens S, Wojcikiewicz RJH (2009) An endoplasmic reticulum (ER) membrane complex composed of SPFH1 and SPFH2 mediates the ER-associated degradation of inositol 1,4,5-trisphosphate receptors. J Biol Chem 284(16):10433–10445. https://doi.org/10.1074/jbc.M809801200
doi: 10.1074/jbc.M809801200
pubmed: 19240031
pmcid: 2667730
Pednekar D, Wang Y, Fedotova TV, Wojcikiewicz RJH (2011) Clustered hydrophobic amino acids in amphipathic helices mediate Erlin1/2 complex assembly. Biochem Biophys Res Commun 415(1):135–140. https://doi.org/10.1016/j.bbrc.2011.10.032
doi: 10.1016/j.bbrc.2011.10.032
pubmed: 22020079
pmcid: 3242435
Jaganathan K, Kyriazopoulou Panagiotopoulou S, McRae JF et al (2019) Predicting splicing from primary sequence with deep learning. Cell 176(3):535–548. https://doi.org/10.1016/j.cell.2018.12.015
doi: 10.1016/j.cell.2018.12.015
pubmed: 30661751
Prole DL, Taylor CW (2019) Structure and function of IP3 receptors. Cold Spring Harb Perspect Biol 11(4):a035063. https://doi.org/10.1101/cshperspect.a035063
doi: 10.1101/cshperspect.a035063
pubmed: 30745293
pmcid: 6442203
Rydning SL, Dudesek A, Rimmele F, Funke C, Krüger S, Biskup S, Vigeland MD et al (2018) A novel heterozygous variant in ERLIN2 causes autosomal dominant pure hereditary spastic paraplegia. Eur J Neurol 25(7):943-e71. https://doi.org/10.1111/ene.13625
doi: 10.1111/ene.13625
pubmed: 29528531
Sharp AH, Nucifora FC, Blondel O, Sheppard CA, Zhang C, Snyder SH, Russell JT, Ryugo DK, Ross CA (1999) Differential cellular expression of isoforms of inositol 1,4,5-triphosphate receptors in neurons and glia in brain. J Comp Neurol 406(2):207–20
doi: 10.1002/(SICI)1096-9861(19990405)406:2<207::AID-CNE6>3.0.CO;2-7
pubmed: 10096607
Sobreira N, Schiettecatte F, Boehm C, Valle D, Hamosh A (2015) New tools for mendelian disease gene identification: PhenoDB variant analysis module; and GeneMatcher, a web-based tool for linking investigators with an interest in the same gene. Hum Mutat 36(4):425–31. https://doi.org/10.1002/humu.22769
doi: 10.1002/humu.22769
pubmed: 25684268
pmcid: 4820250
Srivastava S, D’Amore A, Cohen JS, Swanson LC, Ricca I, Pini A, Fatemi A, Ebrahimi-Fakhari D, Santorelli FM (2020) Expansion of the genetic landscape of ERLIN2-related disorders. Ann Clin Transl Neurol 7(4):573–78. https://doi.org/10.1002/acn3.51007
doi: 10.1002/acn3.51007
pubmed: 32147972
pmcid: 7187699
Stevenson J, Huang EY, Olzmann JA (2016) Endoplasmic reticulum-associated degradation and lipid homeostasis. Annu Rev Nutr 36(juillet):511–42. https://doi.org/10.1146/annurev-nutr-071715-051030
doi: 10.1146/annurev-nutr-071715-051030
pubmed: 27296502
pmcid: 6268005
Thorvaldsdóttir H, Robinson JT, Mesirov JP (2013) Integrative genomics viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform 14(2):178–92. https://doi.org/10.1093/bib/bbs017
doi: 10.1093/bib/bbs017
pubmed: 22517427
Tipton PW, Guthrie K, Strongosky A, Reimer R, Wszolek ZK (2017) Spinocerebellar ataxia 15: a phenotypic review and expansion. Neurol Neurochir Pol 51(1):86–91. https://doi.org/10.1016/j.pjnns.2016.10.006
doi: 10.1016/j.pjnns.2016.10.006
pubmed: 27908616
Tunca C, Akçimen F, Coşkun C, Gündoğdu-Eken A, Kocoglu C, Çevik B, Bekircan-Kurt CE, Tan E, Nazlı Başak A (2018) ERLIN1 mutations cause teenage-onset slowly progressive ALS in a large Turkish pedigree. Eur J Hum Genet EJHG 26(5):745–48. https://doi.org/10.1038/s41431-018-0107-5
doi: 10.1038/s41431-018-0107-5
pubmed: 29453415
von Elsner L, Chai G, Schneeberger PE, Harms FL, Casar C, Qi M, Alawi M et al (2021) Biallelic FRA10AC1 variants cause a neurodevelopmental disorder with growth retardation. Brain 145(4):1551–1563. https://doi.org/10.1093/brain/awab403
doi: 10.1093/brain/awab403
Wagner M, Osborn DPS, Gehweiler I, Nagel M, Ulmer U, Bakhtiari S, Amouri R et al (2019) Bi-allelic variants in RNF170 are associated with hereditary spastic paraplegia. Nat Commun 10(1):4790. https://doi.org/10.1038/s41467-019-12620-9
doi: 10.1038/s41467-019-12620-9
pubmed: 31636353
pmcid: 6803694
Wiel L, Baakman C, Gilissen D, Veltman JA, Vriend G, Gilissen C (2019) MetaDome: pathogenicity analysis of genetic variants through aggregation of homologous human protein domains. Hum Mutat 40(8):1030–38. https://doi.org/10.1002/humu.23798
doi: 10.1002/humu.23798
pubmed: 31116477
pmcid: 6772141
Wright FA, Bonzerato CG, Sliter DA, Wojcikiewicz RJH (2018) The Erlin2 T65I mutation inhibits Erlin1/2 complex-mediated inositol 1,4,5-trisphosphate receptor ubiquitination and phosphatidylinositol 3-phosphate binding. J Biol Chem 293(40):15706–14. https://doi.org/10.1074/jbc.RA118.004547
doi: 10.1074/jbc.RA118.004547
pubmed: 30135210
pmcid: 6177578
Young MM, Kester M, Wang H-G (2013) Sphingolipids: regulators of crosstalk between apoptosis and autophagy. J Lipid Res 54(1):5–19. https://doi.org/10.1194/jlr.R031278
doi: 10.1194/jlr.R031278
pubmed: 23152582
pmcid: 3520539
Zhu Z-Y, Li Z-Y, Zhang C, Liu X-L, Tian W-T, Cao Li (2022) A novel homozygous mutation in ERLIN1 gene causing spastic paraplegia 62 and literature review. Eur J Med Genet 65(11):104608. https://doi.org/10.1016/j.ejmg.2022.104608
doi: 10.1016/j.ejmg.2022.104608
pubmed: 36100157